For example, NCAM1 (also known as CD56) is a main carrier for the neural crest stem cell marker and its reduced expression is correlated with unfavorable prognosis in neuroblastoma with distant metastases, regardless of the MYCN amplification status [45, 46]. Here, NCAM1 is linked to neuroblastoma.